Effect of passive smoking as a risk factor for chronic obstructive pulmonary disease in normal healthy women

Authors

  • Meenakshi Kalyan Department of Medicine, Dr. D.Y. Patil Medical College Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune – 411018, Maharashtra, India
  • Shubhangi A. Kanitkar Department of Medicine, Dr. D.Y. Patil Medical College Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune – 411018, Maharashtra, India
  • Aayush Gupta Department of Medicine, Dr. D.Y. Patil Medical College Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune – 411018, Maharashtra, India
  • Devanshi Sharma Department of Medicine, Dr. D.Y. Patil Medical College Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune – 411018, Maharashtra, India
  • Sanam Singh Department of Medicine, Dr. D.Y. Patil Medical College Hospital and Research Centre, Sant Tukaram Nagar, Pimpri, Pune – 411018, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20163800

Keywords:

Environmental tobacco smoke, Pulmonary function tests

Abstract

Background: Environmental tobacco smoke (ETS) is a risk factor for cardiovascular disease, asthma in children and lung cancer. There is a biological plausibility of ETS as a causal factor for COPD. Objectives of the study were to examine the effect of passive smoking on lung function in non-smoking healthy women and to co-relate the effects of passive smoke as a risk factor for COPD.

Methods: 50 women between 20-40 years of age exposed to passive smoke at home and workplace were assessed by questionnaire. The pulmonary function tests were performed and the values of FEV1 and FVC were obtained by a spirometer.

Results: Out of 50 women, 34 % at workplace, 54% at home and 12% at home and workplace were exposed. Mean age was 30.3 years. Mean±SD of FEV1 was 1.94±0.9, FVC was 2.54±1.06, FEV1/FVC was 73.5±10.06 predicted FEV1 % was 63.2±23.2. FEV1/FVC of women exposed at home and workplace was 70.84 indicating that they have higher chances of developing COPD later in life.

Conclusions: Passive smoking represents a serious health hazard that can be prevented by health education campaigns.

References

Fielding JE, Phenow KJ. Health effects of involuntary smoking. New Eng J Medi. 1988;319:1452-60.

Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733-43.

Oberg M, Jakkola MS, Woodward A, Peruga A, Pruss Ustin A. Worldwide burden of disease from exposure to second hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377:139-46.

Anonymous, IUALID, The world tobacco situation. IUALID News Bull Tobacco Health. 1998;11:19-21.

Jakkola MS, Jaakkola JJ. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health. 2002;28(Suppl2):52-70.

Soriano JB, Rodriguez Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors and clinical presentation. Proc Am Thoracic Soc. 2011;8(4):363-67.

Sprauve ME, Lindsay MK, Drews-Botsch CD, Graves W. Racial patterns in the effects of tobacco use on fetal growth. Am J Obstet Gynecol. 1999;181(1):S22-7.

Janson C, Chinn S, Jarvis D, Zock JP, Toren K, Burney P. For the European Community Respiratory Health Survey. Effects of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross sectional study. Lancet. 2001;358:2103-9.

Gardner RM. Standardization of spirometry: a summary of recommendations from the American Thoracic society. The 1987 update. Ann Intern Med. 1988;108(2):217-20.

Rabe KF, Hurd S, Anzueto A. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55.

Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates what is true burden of disease? Chest. 2003;123:1684-92.

Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 2001;17:1024-33.

Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blane PD. Life time environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4:7.

Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, et al. Passive smoking exposure and risk of COPD among adults in China : the Guangzhou Biobank cohort study. Lancet. 2007;370:751-7.

Sezer H, Akkuurt I, Guler N, Marakoglu K, berk S. A case control study on the effect of exposure to different substances on the development of COPD. Ann Epidemiol. 2006;16:59-62.

All Wright S, paul G, Greincer B, Mullally BJ et al. legislation for smoke free workplaces and health of bar workers in Ireland before and after study. BMJ. 2005;331:1117.

Flouris AD, Koutedakis Y. Immediate and short-term consequences of secondhand smoke exposure on the respiratory system. Curr Opin Pulm Med. 201;17(2):110-15.

Eisner, MD. Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma. Environ Health Perspect. 2002;110(8):765-70.

Downloads

Published

2016-12-19

How to Cite

Kalyan, M., Kanitkar, S. A., Gupta, A., Sharma, D., & Singh, S. (2016). Effect of passive smoking as a risk factor for chronic obstructive pulmonary disease in normal healthy women. International Journal of Research in Medical Sciences, 4(11), 4970–4973. https://doi.org/10.18203/2320-6012.ijrms20163800

Issue

Section

Original Research Articles